Chaima K, Fatma H, Nadine K, Chahir K, Emna B, Khadija S, Mariem A, Sonia B, Abderrahman M, Tahya B, Hamida T. Lichen planus pigmentosus post COVID-19-vaccination: A case report with literature review.
Dermatol Ther 2022;
35:e15891. [PMID:
36183151 PMCID:
PMC9538344 DOI:
10.1111/dth.15891]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Revised: 09/17/2022] [Accepted: 09/28/2022] [Indexed: 11/30/2022]
Abstract
Lichen planus (LP) is a T cell‐mediated chronic inflammatory disorder. Several clinical variants based on lesion morphology and localization are reported. LPP remains uncommon with an unknown etiology. Besides, some precipitating factors have been suggested in the literature including hepatitis C infection; restrictive underwear, localized friction, and sun exposure.(1, 2) Herein, we present a case of new‐onset of LPP following the ChAdOx1 nCoV‐19 (Oxford‐AstraZeneca) vaccine. A literature review was also conducted to summarize the various cases of LP induced and/or trigged by Covid‐19 vaccine.
Collapse